Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a positive outlook with strong revenue growth, significant dividend increases, and successful capital raising efforts. Despite the public offering, the company's strategic acquisitions and consistent dividend policy indicate stability and growth. The Q&A section reveals management's confidence in maintaining leverage and securing financing, although there is some uncertainty around Medicaid percentage increases. Overall, the financial performance and strategic initiatives suggest a positive stock price movement in the short term.
Total Revenue $117.3 million (up $17.3 million or 17.3% year-over-year), driven by full-year contributions from the Indiana two master lease acquired in Q3 2023 and revenue from additional acquisitions throughout 2024.
Total Expenses $55.8 million (up $3.4 million or 6.5% year-over-year), primarily due to higher depreciation and amortization costs along with increased general and administrative expenses.
Interest Expense $32.8 million (up $8.2 million or 33.4% year-over-year), reflecting additional expenses incurred to finance the company’s portfolio growth.
Net Income $26.5 million (up $6.3 million or 30.9% year-over-year), as revenue growth outpaced expenses.
Adjusted AFFO $55.8 million, demonstrating year-over-year growth with a compound annual growth rate of 12.6%.
Adjusted EBITDA $90.6 million, demonstrating year-over-year growth with a compound annual growth rate of 8.2%.
Total Assets $170 million (up 27.7% year-over-year), driven by significant portfolio expansion.
Total Liabilities $134.5 million (up 23.6% year-over-year), due to financing activities related to portfolio growth.
Equity $83.5 million (up $36 million or 76.8% year-over-year), reflecting successful capital raising efforts.
Dividend per Share $0.14 (up from $0.12 per share, representing a 16.6% increase in annual dividend distribution per share).
Acquisitions in Canada: The company entered its first agreement for six healthcare facilities located in Canada, with a purchase price of $90 million.
Acquisition of Missouri Facilities: In December, the company completed an acquisition of eight healthcare facilities in Missouri for $87.5 million.
Portfolio Growth: The company grew its portfolio from 109 to 130 facilities, increasing the number of beds from 12,449 to 14,540, a 14% increase.
Base Rent Growth: Base rents increased from $84 million in 2020 to $104 million in 2024, with expectations to reach $130 million in 2025.
Lease Maturity: The average lease term increased from 4.6 years to 7.4 years.
Contractual Rent Collection: The company collected 100% of its contractual rents.
Public Offering: The company completed its first underwritten public offering of approximately 3.34 million shares, raising $35 million.
ATM Program: The company established an ATM program to sell shares to the public for the first time.
Debt Management: The company strategically reduced debt by paying down $24 million on a higher interest loan.
Competitive Pressures: The company is transitioning from a small, mom-and-pop operation to a more competitive entity, aiming to attract institutional investors and increase stock liquidity. This shift may expose the company to greater competitive pressures in the market.
Regulatory Issues: The company is navigating regulatory environments as it expands into new states and countries, which may present challenges in compliance and operational execution.
Supply Chain Challenges: The company has increased its portfolio significantly, which may lead to supply chain challenges in managing and maintaining the facilities across multiple states.
Economic Factors: The company faces economic uncertainties that could impact its growth and profitability, particularly in the context of rising interest rates and inflation affecting operational costs.
Debt Management: The company has increased its total liabilities by 23.6% to $134.5 million, raising concerns about debt management and the ability to service this debt amid rising interest expenses.
Lease Renewals: The company has several leases maturing in 2025, which poses a risk if tenants do not renew, potentially impacting cash flow.
Market Volatility: The stock price has experienced volatility, particularly after public offerings, which may affect investor confidence and market perception.
Portfolio Growth: Acquired $130.3 million in grocery, increasing facilities from 109 to 124 and beds from 12,449 to 14,186, a 14% increase.
Tenant Base Expansion: Grew tenant base from 10 operators to 40, with 88% of facilities tied to master leases.
Lease Maturity: Average lease term increased from 4.6 years to 7.4 years, with 6 leases maturing in 2025.
Public Offering: Completed first underwritten public offering of approximately 3.34 million shares for total gross proceeds of $35 million.
Acquisitions: Acquired 8 healthcare facilities in Missouri for $87.5 million and 6 facilities in Canada for $90 million.
Revenue Expectations: Expect base rents to increase from $104 million in 2024 to approximately $130 million in 2025.
Dividend: Authorized cash dividend of $0.14 per share, representing a 16.6% increase from the previous year.
Debt Management: Plan to reduce debt by bringing in less expensive debt and selling shares through ATM to pay down debt.
Future Growth: Expect continued growth in AFFO per share and stable rent collection.
Stock Performance: Aim for stock to trade at a multiple of 13-14 times FFO.
Dividend per share: $0.14 per share, payable on March 31, 2025, to shareholders of record on March 17, 2025.
Consecutive quarters of dividend payments: This will be the tenth consecutive quarter of paying a dividend.
Annual dividend increase: Increased from $0.12 per share at the beginning of 2024 to $0.14 per share by year-end, representing a 16.6% increase.
Dividend yield: 5.3% with an AFFO payout of 49.5%.
Public offering: Completed its first underwritten public offering of approximately 3.34 million shares of common stock for total gross proceeds of $35 million.
ATM program: Established an ATM program to sell shares to the public.
The earnings call indicates strong financial performance with increased revenue, net income, and dividend growth. The company has a balanced capital structure and plans for further acquisition growth. The Q&A section reveals proactive management strategies, including refinancing plans and strategic divestitures. Despite some unclear responses, the overall sentiment from the earnings and Q&A is positive, bolstered by dividend increases and acquisition plans. The lack of negative sentiment in analyst questions and management's optimistic outlook suggest a positive stock price movement in the short term.
The earnings call presents a positive outlook with strong revenue growth, significant dividend increases, and successful capital raising efforts. Despite the public offering, the company's strategic acquisitions and consistent dividend policy indicate stability and growth. The Q&A section reveals management's confidence in maintaining leverage and securing financing, although there is some uncertainty around Medicaid percentage increases. Overall, the financial performance and strategic initiatives suggest a positive stock price movement in the short term.
The earnings call summary reveals strong financial performance, with increased revenue, net income, and dividends, alongside strategic acquisitions. The Q&A session highlights a robust deal pipeline and confidence in leverage management. While there is uncertainty about the Medicaid payer mix, overall sentiment remains positive due to growth in assets and shareholder returns, despite the public offering potentially diluting shares. The absence of a market cap suggests a neutral to positive reaction, but given the strong financials and optimistic guidance, a 'Positive' sentiment is appropriate.
The earnings call reveals positive financial performance, with increased assets, equity, and a higher dividend payout, indicating confidence in future growth. The Q&A section raised some concerns regarding Medicaid reimbursements, but overall sentiment remained positive, particularly with the expected FFO growth and base rent increase. The ATM program and increased liquidity are also favorable. While there are risks like regulatory issues and debt management, the optimistic guidance and shareholder return plan, coupled with a strong dividend history, suggest a positive stock price movement in the near term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.